eduKateSG · Why Science?
Connect cell-type ligand–receptor co-expression to receptor-to-regulator paths and developmental tests—without treating a reconstructed path as observed signal flow
Reading routes
Science learning becomes useful when a familiar object or observation is turned into a system of quantities, mechanisms and claim limits. This guide owns one applied evidence-reading job inside eduKateSG’s wider Science estate. It connects naturally to Why Science Domino Transcription Factor Activation Ligand Receptor Network Evidence; Why Science Cellcall Ligand Receptor Transcription Factor Pathway Evidence; Why Science Scseqcomm Intercellular Intracellular Signalling Paths Functional Evidence; Why Science Nichenet Active Ligands Target Gene Regulatory Evidence; Education Hub; Singapore Secondary School Directory; Career Adulthood Hub. It also keeps current school and public claims traceable to visible primary sources: CellComm primary study; CellComm PubMed record; CellComm full-text record; Official FUSCA repository containing CellComm; Primary-study GEO record; 2026 Singapore–Cambridge O-Level Biology syllabus; MOE G2/G3 Lower Secondary Science syllabus; 2026 MOE G2 Computing syllabus. The sources describe the scientific scope; this article translates that scope into a calm route for Primary Science, PSLE Science, Secondary Science, O-Level Science, STEM exploration, school choices and career pathways without inventing admission or employment outcomes.
CellComm is a cell–cell communication method introduced in a 2022 Nature Cell Biology study of haematopoietic stem and progenitor cell development. It uses cell-type co-expression of curated ligand–receptor pairs, then searches weighted protein-interaction networks for paths from receptors to downstream transcriptional regulators and prioritises regulators through regulon enrichment. The published study combined computational predictions with zebrafish, mouse and human evidence. Those validations belong to the reported developmental system; CellComm output in a new tissue remains a model-derived hypothesis requiring its own spatial, protein, temporal and perturbation support.
Inside this guide
1–12 · Foundations and models
- 1. Start with developmental crosstalk
- 2. Keep the 2022 paper boundary
- 3. Find co-expressed ligand–receptor pairs
- 4. Use spatial evidence when available
- 5. Search receptor-to-regulator paths
- 6. Prioritise regulators by regulons
- 7. Separate inference layers
- 8. Create a specimen manifest
- 9. Audit cell identities
- 10. Freeze the ligand–receptor resource
- 11. Freeze the protein network
- 12. Freeze the regulon resource
13–24 · Evidence, testing and applications
- 13. Protect biological replication
- 14. Archive the full path
- 15. Practise with an invented evidence table
- 16. Read pair abundance cautiously
- 17. Inspect cell-type specificity
- 18. Inspect every intermediate node
- 19. Read regulon enrichment transparently
- 20. Compare pathways, not just ranks
- 21. Use developmental time
- 22. Audit spatial constraints
- 23. Audit path-search choices
- 24. Audit regulon sensitivity
25–36 · Learning, decisions and pathways
- 25. Compare simpler baselines
- 26. Publish informative negatives
- 27. Design a staged perturbation
- 28. Write a bounded CellComm claim
- 29. Turn development into a classroom chain
- 30. Begin with Primary Science habits
- 31. Use PSLE Science for fair tests
- 32. Connect Secondary and O-Level Science
- 33. Let Computing support the path
- 34. Choose opportunities by verified fit
- 35. See connected career families
- 36. Finish with the chain intact
Section 1 of 36
1. Start with developmental crosstalk
CellComm was built to ask how cell types in a developing microenvironment may influence one another. It begins with cell-type expression and curated ligand–receptor relationships, then follows candidate receptor signals towards transcriptional regulators. The result is a traceable hypothesis chain, not a recording of molecules moving through tissue.
Section 2 of 36
2. Keep the 2022 paper boundary
The primary Nature Cell Biology study analysed the aorta–gonad–mesonephros environment during haematopoietic stem and progenitor cell emergence. Its validations in zebrafish, mouse and human models support conclusions in that developmental programme. They do not automatically validate every CellComm prediction in another organ, age or disease.
Section 3 of 36
3. Find co-expressed ligand–receptor pairs
CellComm identifies candidate communication by examining curated ligand–receptor pairs whose members are expressed in source and receiver cell types. Co-expression supplies compatibility. It cannot show that a ligand was processed or released, that a receptor reached the cell surface, or that binding occurred.
Section 4 of 36
4. Use spatial evidence when available
When spatial transcriptomics is available, potential interactions can be constrained by location. Compatible cell types that occupy the same niche offer stronger opportunity than distant groups. Spatial proximity remains opportunity, not molecular transfer, and the appropriate distance depends on whether a signal is contact-bound or diffusible.
Section 5 of 36
5. Search receptor-to-regulator paths
CellComm uses an optimisation procedure to search a weighted protein-interaction network for paths from cell-surface receptors to downstream transcriptional regulators. A high-ranking path connects prior molecular knowledge with sample expression. It does not directly observe every intermediate protein or biochemical step.
Section 6 of 36
6. Prioritise regulators by regulons
Candidate transcriptional regulators are evaluated using enrichment of their regulons in cell-type-specific expression signatures. This adds a downstream-response layer. Regulon enrichment is still an inference based on gene sets, not direct evidence of regulator protein activity or DNA binding.
Section 7 of 36
7. Separate inference layers
Ligand and receptor RNA, spatial opportunity, network paths and regulon enrichment are different forms of evidence. Label them separately. The attraction of CellComm is that the layers can be connected; the scientific discipline is refusing to merge them into one unqualified claim of communication.
Section 8 of 36
8. Create a specimen manifest
Record organism, developmental stage, tissue, condition, biological specimen, assay, preprocessing, cell annotations and spatial technology. Development changes quickly, so stage and anatomical compartment are part of the question rather than optional metadata.
Section 9 of 36
9. Audit cell identities
Check markers, doublets, transitional populations and specimen balance for every source and receiver group. The AGM contains closely related developmental states. A fragile label can create an apparently specific route that disappears when cells are grouped more conservatively.
Section 10 of 36
10. Freeze the ligand–receptor resource
Archive the exact pair table, species, identifiers, direction and complex rules. Database updates can add or remove eligible edges without any change to the tissue. A versioned pair universe keeps knowledge-base change separate from biological change.
Section 11 of 36
11. Freeze the protein network
Preserve the protein–protein interaction resource, weights, direction assumptions and filters used for receptor-to-regulator path finding. Highly studied pathways are richer than neglected ones, so network coverage can shape which regulators appear reachable.
Section 12 of 36
12. Freeze the regulon resource
Save the transcriptional regulators, target sets and enrichment background. Report target-set size for leading regulators. A regulator with a large, broadly annotated regulon can be enriched more readily than one with sparse evidence.
Section 13 of 36
13. Protect biological replication
Cells are nested inside embryos, animals, donors or samples. Estimate route support within each independent specimen and report prevalence. Thousands of single cells improve resolution but do not create thousands of independent developmental systems.
Section 14 of 36
14. Archive the full path
Keep expression summaries, cell labels, spatial coordinates, pair mappings, path-search settings, network edges, regulon tests, thresholds and complete ranked results. A network figure cannot reveal which layer supplied the decisive evidence.
Section 15 of 36
15. Practise with an invented evidence table
This fictional table is for reasoning practice, not CellComm output. Identify the weakest link before choosing an experiment.
| Fictional route | Pair evidence | Downstream evidence | Main next check |
|---|---|---|---|
| Route A | Replicated | Stable regulator | Receptor protein |
| Route B | Spatially plausible | Network-sensitive | Pathway assay |
| Route C | Strong expression | One specimen | Replication |
| Route D | Curated pair | No regulator support | Receiver response |
Section 16 of 36
16. Read pair abundance cautiously
A highly expressed ligand–receptor pair can dominate a network while remaining biologically inactive. Publish distributions and detection fractions rather than means alone. Check whether the signal is spread across cells and specimens or driven by a small, noisy subset.
Section 17 of 36
17. Inspect cell-type specificity
Compare a route with other possible source and receiver groups. A pair expressed everywhere may be important but is not specific evidence for one developmental interaction. Specificity should be demonstrated, not inferred from an attractive cell-pair label.
Section 18 of 36
18. Inspect every intermediate node
For a receptor-to-regulator path, list the intermediate proteins, edge provenance and sample expression. Missing expression does not always mean an inactive protein, but repeated gaps weaken a sample-specific path and should remain visible.
Section 19 of 36
19. Read regulon enrichment transparently
Publish the target genes, background universe, statistic and correction. Broad developmental signatures can enrich many regulators. A useful regulator claim shows which genes carry the result and whether the enrichment repeats across specimens.
Section 20 of 36
20. Compare pathways, not just ranks
Two receptor-to-regulator paths can reach the same regulator through different molecular intermediates. Compare pathway plausibility, expression support and experimental discriminability. The top numerical rank is not automatically the best biological explanation.
Section 21 of 36
21. Use developmental time
A route proposed during cell emergence should match stage order. Measure ligand availability, receptor-proximal events and regulator response across justified time points. A single snapshot can mix cells that occupy different moments along a developmental trajectory.
Section 22 of 36
22. Audit spatial constraints
Repeat the analysis with biologically reasonable neighbourhood definitions and anatomical compartments. Contact-dependent signals should require close opportunity; diffusible factors may act farther away. A single generic radius cannot represent every mediator.
Section 23 of 36
23. Audit path-search choices
Vary planned edge confidence, maximum path length and weight settings. Long paths can connect many receptors to familiar regulators by chance. Stable conclusions should persist under defensible alternatives and should not depend on one low-confidence bridge.
Section 24 of 36
24. Audit regulon sensitivity
Compare compatible regulator resources or high-confidence target subsets. Mark predictions that vanish when uncertain targets are removed. Resource sensitivity is not a failure; it tells experimentalists which evidence link is weakest.
Section 25 of 36
25. Compare simpler baselines
Compare CellComm with ligand–receptor expression alone and with regulator enrichment alone. The integrated method adds value when its linked path creates a stable, discriminating prediction that the two components do not reveal separately.
Section 26 of 36
26. Publish informative negatives
Show routes rejected by absent spatial opportunity, unstable cell labels, missing receptor protein, weak regulator enrichment or specimen disagreement. These cases demonstrate how the evidence chain filters hypotheses instead of simply drawing more edges.
Section 27 of 36
27. Design a staged perturbation
Block a leading ligand or receptor and measure an early pathway event, the nominated regulator and a later developmental outcome. Include a competing route. This separates molecular specificity from a general stress or maturation effect.
Section 28 of 36
28. Write a bounded CellComm claim
Prefer: ‘CellComm prioritised this ligand–receptor–regulator path across three specimens, with spatial and regulon support.’ Avoid saying CellComm proved signal transfer. The bounded statement preserves the method’s real contribution and makes validation straightforward.
Section 29 of 36
29. Turn development into a classroom chain
Give students cards for source cell, ligand, receptor, pathway, regulator and target genes. Ask which cards are observations, database links or predictions. Then remove one card and decide how the claim changes.
Section 30 of 36
30. Begin with Primary Science habits
Observation, classification and careful sequencing are the roots of a developmental evidence chain. Young learners can already distinguish what happened first, what was measured and which explanation remains possible.
Section 31 of 36
31. Use PSLE Science for fair tests
Students can compare two routes and choose one variable to change. Predicting the early and late outcomes of blocking a ligand practises cause-and-effect reasoning without requiring advanced genomics.
Section 32 of 36
32. Connect Secondary and O-Level Science
Cells, receptors, coordination, gene expression and development provide the biological language. CellComm adds networks and evidence integration. The aim is to evaluate a pathway, not memorise software names.
Section 33 of 36
33. Let Computing support the path
Computing contributes graphs, optimisation, weights, enrichment, version control and reproducible code. Biology determines whether nodes and directions are meaningful. A correct shortest path can still be biologically implausible.
Section 34 of 36
34. Choose opportunities by verified fit
For school choices or science enrichment, check current official details and look for sustained opportunities in biology, data handling, computing and research. Programme names do not guarantee admission, equipment or a particular outcome.
Section 35 of 36
35. See connected career families
The reasoning connects to developmental biology, haematology, bioinformatics, regenerative medicine, statistics, research software and experimental science. Education routes vary, so verify current institutional and employer requirements directly.
Section 36 of 36
36. Finish with the chain intact
A defensible CellComm conclusion names the specimens, pair resource, spatial rule, protein network, path settings and regulon evidence, then separates the reconstructed route from molecular and developmental validation. The path is valuable because every link can be tested.
CellComm is most useful when its output is read as a chain of evidence rather than a single colourful network. The first link is cell-type-level ligand–receptor co-expression. The second is a candidate path through a weighted protein–protein interaction network from a receptor towards a transcriptional regulator. The third is regulon enrichment, which asks whether genes associated with that regulator are supported in the receiver state. Each link answers a different question, and none directly measures signal transmission.
Did you know? The CellComm method was presented in a developmental study spanning zebrafish, mouse and human evidence. That breadth strengthened the paper’s claims about its reported haematopoietic system, but it does not make every CellComm prediction in a new tissue experimentally validated. Reuse the method; do not copy the validation status.
Start by preserving the biological unit. Cells from one specimen are not independent replicates of the treatment. Summarise candidate routes by donor, embryo, animal or other true unit, then ask whether the route recurs. A high score driven by one large specimen is a lead for inspection, not a population-level result.
Co-expression also needs a visible denominator. Report the fraction of cells expressing each partner, the number of eligible cells and the aggregation rule used for each cluster. A ligand detected in three cells out of three has a different evidence base from one detected in three cells out of three thousand. Keep low-count groups and dropout sensitivity in the table.
Spatial constraints are optional only when spatial evidence is unavailable. If coordinates or anatomical regions exist, define a contact or diffusion opportunity before ranking the biological story. Membrane-bound interactions usually require a tighter neighbourhood than secreted signals. Repeat the result across reasonable distance thresholds and show whether the claimed source–receiver pairing survives.
The receptor-to-regulator search depends on a prior network. Freeze its release, identifier namespace, species mapping and edge weights. Inspect the complete path behind a headline route. A short path composed of well-supported edges and a long path assembled from generic hubs should not receive the same prose. Hub proteins can connect many endpoints without establishing context-specific activity.
Regulon enrichment provides response-side evidence, but a regulon is itself an inference resource. Show the target genes supporting a regulator, their direction and their specimen prevalence. Recalculate after removing one dominant target. If the ranking collapses, report that fragility instead of presenting the regulator as a stable endpoint.
Validation should climb a ladder. First confirm cell identities and expression in independent specimens. Next localise ligand and receptor proteins. Then assay a receptor-proximal event or regulator activation. Finally perturb the ligand, receptor or route and test the predicted receiver programme. Each rung addresses a different gap; one successful immunostain does not validate the whole path.
Negative controls can be beautifully specific. Shuffle sender labels within specimen while preserving abundance. Test a receptor-free receiver group. Compare the nominated regulator with an expression-matched alternative. Use an anatomical compartment where the pair should lack opportunity. A method that keeps ranking the same route under these controls may be following broad expression or network connectivity.
For students, CellComm joins familiar scientific habits. Primary Science begins with observation and classification. PSLE Science strengthens fair comparison. Secondary and O-Level Biology add receptors, regulation and development. Computing adds graphs, shortest paths and reproducible data handling. The advanced workflow still depends on the simple question: which parts were observed, and which were inferred?
A good report includes an evidence ledger for each headline path: ligand expression, receptor expression, source and receiver counts, spatial opportunity, prior-network path, regulator targets, replicate support, protein evidence and perturbation status. Mark each field as observed, inferred, unsupported or not tested. This makes the result navigable and prevents an absent experiment from being mistaken for a negative result.
Compare CellComm with a simpler baseline. If ligand–receptor co-expression alone produces the same ranking, the downstream path may add explanation rather than discrimination. If regulator evidence changes the priority, show exactly why. The comparison helps readers understand what the extra modelling contributes.
Version the analysis as carefully as the data. Archive the CellComm/FUSCA code revision, dependency environment, interaction resource, network object, regulon set, parameters and random seeds. A future database update may reroute a receptor to another regulator. Provenance tells readers that the analytical knowledge changed; the original sample did not.
The bounded conclusion is already valuable: CellComm can prioritise traceable ligand–receptor and receptor-to-regulator hypotheses for developmental or other single-cell studies. It does not directly observe ligand release, receptor binding, biochemical activation, direction of information flow or causal regulation. Keeping those verbs precise turns a network into a better experiment plan.
Before publication, run one final pathway audit. Trace every displayed arrow to either the sample data, a named prior resource or a clearly labelled calculation. Remove isolated nodes that do not affect the interpretation. Check that the article never shifts from “co-expressed”, “connected” or “prioritised” to “activated” without additional evidence. This small language review is a powerful defence against accidental overclaiming.
Plan the next experiment around the weakest link rather than the most familiar technique. If spatial opportunity is uncertain, improve localisation. If the receptor-to-regulator path depends on a generic hub, assay a proximal event. If the regulon is unstable, measure targets after controlled perturbation. Science progresses fastest when the validation step is chosen to discriminate among explanations.
Finally, retain alternatives. A receiver programme may be produced by several receptors, and a ligand may act through several receivers. Rank plausible competing paths and state what observation would separate them. A network becomes scientifically useful when it supports a decision about what to test next, not merely when it contains many arrows.
Contents · Previous section · Continue to the Science Learning Hub
